Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

DBCOND0067384Cardiovascular Diseases Respiratory Tract Diseases

Chronic Thromboembolic Pulmonary Hypertension (CTEPH) is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as: Chronic Thromboembolic Pulmonary Hypertension · CTEPH · Pulmonary Hypertension Chronic Thromboembolic · Thromboembolic Pulmonary Hypertension
Classified under: Cardiovascular Diseases
Respiratory Tract Diseases
Indicated drugs: Riociguat

Resolves to

Vocabularies

ICD-10I27.20SNOMED CT233947005MedDRA10037401UMLSC0020542

What you can answer from here — as of October 25, 2026

1Indicated drugWith each drug's targets and mechanism

Listed above

1Structured indicationPopulation, line of therapy, route and combination as fields, not prose

30Clinical trialsPhase, status and sponsor resolved per trial

1Drug reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Chronic Thromboembolic Pulmonary Hypertension (CTEPH) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account